Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the investment in XPartners
Mandate

Vinge advises Axcel in connection with the investment in XPartners

May 03, 2023 M&A Real Estate and Construction Data protection and processing of personal data Corporate Crime & Compliance Employment and Benefits EU, Competition and Regulatory

Vinge has advised Axcel in connection with the investment in XPartners Samhällsbyggnad (“XPartners”), a sustainability-focused technical consulting group, specialising in infrastructure, public and commercial buildings as well as environmental services.

Following Axcel’s investment, the XPartners’ group consists of nine business units employing approximately 400 people across 30 offices in Sweden, generating approximately SEK 600 million in revenue. XPartners is the first investment of Axcel Fund VII.

For more information about the transaction, please see the client’s press release.

Vinge’s team consisted primarily of Christina Kokko, Karl Klackenberg, Carl Fredrik Wachtmeister, Egil Svensson and Elsa Strandberg (M&A), Daniel Prawitz (Construction), Daniel Melander Björner and Tove Hallbäck (Employment), Mikael Ståhl, Seyran Sahin, Karl-Gustaw Tobola and Ida Redander (Financing), Alexandra Tamm (Real Estate), Tove Tullberg and Julia Löfqvist (Compliance), Lisa Hörnqvist (GDPR), Trine Osen Bergqvist, Victoria Fredén and Alva Chambert (ECR) and Emy Rydén (project assistant).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026